Buckeyes - Great post. The only thing that I would add, and you touched on it briefly, is the share ownership composition. RVX is a Canadian biotech. Canada doesn't really have a biotech industry to speak of. We have a  relatively small population and generally more conservative investors than south of the boarder.

Look at our major shareholders, HL a Chinese concern, Eastern a carabean concern, Boeringer a European concern and there is another Chinese company that has taken up a few percent of the company in the last year or so. I have heard but not been able to varify that the funds for the Third Eye loan is from a group of US investors. Whether there is any truth to that doesn't really matter anyway. No matter where those funds came from its a loan which is more conservative from an investment point of view than an equity investment is. When I look over the last 11/12 years that I have been a shareholder I am truely amazed that RVX is still able to not only keep there doors open but coninue to fund BoM and develop other indications along the way.

Someone mentioned that we would have a unicorn if BoM hit on diabetic cardio, CKD and cognitive impairment. Given that this looks to be a spectacular technology developed in a country that doesn't really have a biotech industry, with mostly conservative investors and a government, on pretty much every level, that doesn't seem to have much interest in developing a biotech industry, this could actually be an appaloosa unicorn. Nobody has ever heard of that.    

tada